Open access peer-reviewed Edited Volume


Svetlana P. Chapoval

University of Maryland

Assistant Professor at the University of Maryland School of Medicine, well-recognized for her work on HLA Class II-restricted allergen T cell epitopes, VEGF-induced lung DC modifications, and her recent discoveries on neuroimmune semaphorins 4A and 4D contributions to allergic airway inflammation and to Treg cell phenotype and function. She has served and continues to serve as a reviewer for over 20 peer-reviewed scientific journals.


Th2 Response Th2 Cytokines Asthma Classification Differences in Diagnostics FDA-Approved Treatments Occupational Asthma Exercise-Provoked Asthma Medication-Induced Asthma Th2-Independent Asthma Asthma and COPD Future Perspectives Asthma Research

Register your interest in contributing to this book

Collaborate with our community and contribute your knowledge.

About the book

Asthma is a chronic inflammatory disease of the airways accompanied by variable bronchial hyperresponsiveness with heterogenic genetic and environment interplay. Despite recent advances in disease diagnostics and treatments, asthma is either under- or over-diagnosed and, therefore, often mistreated. The disease is on a rise worldwide currently affecting over 330 million people with around 1000 people dying of asthma each day.

This book will provide the latest understandings of the basics on cellular and molecular mechanisms of asthma, an overview of current FDA-approved treatments, and how they work. In addition to Th2-type allergic asthma, its subtypes and distinctions in treatment options, this book provides recent updates on non-Th2-type or mixed-type asthma such as occupational, medication-induced, and exercise-provoked asthma. New genomics and proteomics technologies help to improve our understanding of the important undelaying pathways and to facilitate novel therapeutic and immunomodulatory agents. The future perspectives in disease prevention and treatment will also be analyzed and discussed.

Publishing process

Book initiated and editor appointed

Date completed: October 26th 2020

Applications to edit the book are assessed and a suitable editor is selected, at which point the process begins.

Chapter proposals submitted and reviewed

Deadline Extended: Open for Submissions

Potential authors submit chapter proposals ready for review by the academic editor and our publishing review team.

Approved chapters written in full and submitted

Deadline for full chapters: January 22nd 2021

Once approved by the academic editor and publishing review team, chapters are written and submitted according to pre-agreed parameters

Full chapters peer reviewed

Review results due: April 12th 2021

Full chapter manuscripts are screened for plagiarism and undergo a Main Editor Peer Review. Results are sent to authors within 30 days of submission, with suggestions for rounds of revisions.

Book compiled, published and promoted

Expected publication date: June 11th 2021

All chapters are copy-checked and typesetted before being published. IntechOpen regularly submits its books to major databases for evaluation and coverage, including the Clarivate Analytics Book Citation Index in the Web of ScienceTM Core Collection. Other discipline-specific databases are also targeted, such as Web of Science's BIOSIS Previews.

About the editor

Svetlana P. Chapoval

University of Maryland

Dr. Svetlana Chapoval completed her medical training in 1985 at Russian State Medical University and PhD training in 1994 at Gamaleya Scientific Research Institute of Epidemiology and Microbiology. She then completed her postdoctoral fellowship in Immunology at Mayo Clinic in 2002. From 2002 to 2005 Dr. Chapoval was an Associate Research Scientists in the Department of Pulmonary and Critical Care Medicine at Yale University. She joined the Center for Vascular and Inflammatory Diseases and the Program in Oncology of the University of Maryland Marlene and Stewart Greenebaum Cancer Center at University of Maryland School of Medicine in 2006 as an Assistant Professor. Dr. Chapoval’s research is focused on cellular and molecular mechanisms of lung chronic inflammatory diseases, asthma in particular, and novel molecules for disease immunotherapy. She is well-recognized for her work on HLA Class II-restricted allergen T cell epitopes, VEGF-induced lung DC modifications, and her recent discoveries on neuroimmune semaphorins 4A and 4D contributions to allergic airway inflammation and to Treg cell phenotype and function. Dr. Chapoval has served and continue to serve as a reviewer for 20+ peer-reviewed scientific journals. In 2015, she completed a 4-year term as an Associate Editor for a renowned journal.

View profile

Book chapters authored 3

Books edited 1

Introducing your Author Service Manager

Mr. Josip Knapic

As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copy-editing and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact.

Ask a question

Book will be abstracted and indexed in